Sign up Australia
Proactive Investors - Run By Investors For Investors

Ellex Medical Lasers expanding production capacity to meet rising demand

The sales performance of the company’s device was strong during the 2017 financial year.
A human eye
This second stage production expansion is expected to be completed by July 2018

Ellex Medical Lasers Limited (ASX:ELX) is increasing the production of its iTrack™ microcatheter to circa 50,000 units per annum from the current level of circa 20,000 units per annum.

The company’s illuminated microcatheters are used by physicians to perform canaloplasty for glaucoma patients.

Ellex is aiming to upgrade the production to 50,000 units per annum by expanding its manufacturing facility in Fremont, California.

In July 2017, the production capacity at Fremont was upgraded from 10,000 units per annum to 20,000 units per annum.

This second stage production expansion is expected to be completed by July 2018, by adding clean room facilities in an adjacent building and by recruiting additional technical staff.

In addition, a third stage production capacity increase to more than double the 50,000 units per annum in order to maintain supply for future demand, is currently being planned.

Ellex has witnessed material sales growth in the U.S., supported by an increase in marketing and sales spend.

Importantly, the sales performance of the Ellex’s iTrack™ technology was strong during the 2017 financial year, with sales of $8.2 million.

This represents a 41% annual growth in unit sales compared to the prior comparable period.

Sales outside of the U.S. were $3.5 million, an uplift of 49% on the prior comparable period

The expansion of the Fremont production facility will be funded from the group’s existing cash resources and earnings.

View full ELX profile View Profile

Ellex Medical Lasers Timeline

Newswire
November 30 2016

Related Articles

couple looking at pregnancy test
November 13 2017
The proceeds from the fundraiser will be used to expand in the People's Republic and will invested in product development
scientist looking through microscope
April 12 2018
Kumaraguru Raja sees “multiple catalysts” in the year ahead which could put a rocket under the share price
laboratory
April 12 2018
Mission is to make stem cell treatments accessible and affordable to as many people as possible

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use